The overall objective of the Analytical Chemistry Core is to provide analytical support for the human monitoring, animal model, and cell biology projects in the program project. We will apply techniques to the research projects as appropriate, and will advance the technology upon which the analytical methodology is based. This core will conduct new analyses on serum samples from the CHARGE study, collected during the previous funding period, new samples from the CHARGEBACK and MARBLES study (see Projects 1 and 2). We will evaluate new methods to apply to the prospective study of future siblings and to test specific hypotheses. A major goal will be to generate data sets of xenobiotic exposure and metabolomic biomarkers to regress against transcriptome and proteome data by determining both xenobiotic exposure and levels of endogenous metabolites on selected . We will evaluate metabolite profiles in animal models emphasizing immune dysfunction. In human samples, we will pay particular attention to metabolites indicative of inflammatory status and plasma leptin levels recently found as a biomarker to distinguish between early onset and clinical regression autism. We also will monitor the metabolite profiles in T cells, B cells and natural killer (NK) cells of normal and autistic children with and without exposure to xenobiotics. Of equal importance we will provide a walk up instrument and consultation service in analytical chemistry for the entire core the Specific Aims are: 1. Establish the metabolic pathways responsible for variations in lipid composition between autistic children and their siblings and between normal and immunologically challenged animal models of autism. 2. Use global metabolomic procedures to search for biomarkers of autism. 3. Provide analytical data on pesticide and other xenobiotic levels in cell and in vivo model systems and in serum samples from the CHARGE, CHARGE-BACK, MARBLES, and other successor studies. 4. Develop new analytical methods for xenobiotics of interest to scientists in the program project.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZES1-LKB-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Davis
United States
Zip Code
Dunaway, Keith W; Islam, M Saharul; Coulson, Rochelle L et al. (2016) Cumulative Impact of Polychlorinated Biphenyl and Large Chromosomal Duplications on DNA Methylation, Chromatin, and Expression of Autism Candidate Genes. Cell Rep 17:3035-3048
Martínez-Cerdeño, Verónica; Camacho, Jasmin; Fox, Elizabeth et al. (2016) Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals. Cereb Cortex 26:374-83
Crawley, Jacqueline N; Heyer, Wolf-Dietrich; LaSalle, Janine M (2016) Autism and Cancer Share Risk Genes, Pathways, and Drug Targets. Trends Genet 32:139-46
Sirish, Padmini; Li, Ning; Timofeyev, Valeriy et al. (2016) Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation. Circ Arrhythm Electrophysiol 9:
Keil, Kimberly P; Lein, Pamela J (2016) DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? Environ Epigenet 2:
Aschner, Michael; Ceccatelli, Sandra; Daneshian, Mardas et al. (2016) Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX :
Ciernia, Annie Vogel; LaSalle, Janine (2016) The landscape of DNA methylation amid a perfect storm of autism aetiologies. Nat Rev Neurosci 17:411-23
Saldarriaga, Wilmar; Lein, Pamela; González Teshima, Laura Yuriko et al. (2016) Phenobarbital use and neurological problems in FMR1 premutation carriers. Neurotoxicology 53:141-7
Matelski, Lauren; Van de Water, Judy (2016) Risk factors in autism: Thinking outside the brain. J Autoimmun 67:1-7
Bal-Price, Anna; Lein, Pamela J; Keil, Kimberly P et al. (2016) Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. Neurotoxicology :

Showing the most recent 10 out of 279 publications